Resurgent malaria at the millennium: Control strategies in crisis

Drugs

Volumn 59, Issue 4, 2000, Pages 719-743

  Baird, J Kevin ^a  

^a US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CHLORPHENOTANE; FANSIDAR; MEPACRINE; PESTICIDE; QUININE;

AFRICA; DRUG COST; ENDEMIC DISEASE; FINANCIAL MANAGEMENT; HEALTH PROGRAM; HUMAN; INFECTION RISK; MALARIA; MALARIA FALCIPARUM; MORTALITY; MULTIDRUG RESISTANCE; NAUSEA; PESTICIDE SPRAYING; REVIEW; TINNITUS; VECTOR CONTROL; VERTIGO; WORLD HEALTH ORGANIZATION;

ARACHNIDA; CINCHONA PUBESCENS; HEXAPODA;

EID: 0034092160     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200059040-00001     Document Type: Review

References (83)

1. 1. Harrison G. Mosquitoes, malaria and man: a history of the hostilities since 1880. London: John Murray, 1978: 314
2. 2. Krogstad DJ. Malaria as a reemerging disease. Epidemiol Rev 1996; 18: 77-89
3. 3. Mouchet J, Manguin S, Sircoulon J, et al. Evolution of malaria in Africa for the past 40 years: impact of climatic and human factors. J Am Mosquito Control Assoc 1998; 14: 121-30
4. 4. World Health Organization. Implementation of the global malaria control strategy. WHO Technical Report Series no. 839. Geneva: WHO, 1993
5. 5. World Health Organization. Malaria fact sheet no.94. Geneva: WHO, 1998
6. 6. Nye ER, Gibson ME. Ronald Ross: malariologist and polymath. London: Macmillan Press, 1996: 316
7. 7. Boyd MF. Historical review, In: Boyd MF, editor. Malariology. Philadelphia: WB Saunders, 1949: 3-25
8. 8. Ross R. On some peculiar pigmented cells found in two mosquitoes fed on malarial blood. BMJ 1897; ii: 1786-8
9. 9. Grassi B, Bignami A, Bastianelli G. Ulteriori ricerche sul ciclo dei parassiti malarici umani nel corpo del zanarone. Atti Reale Accademia dei Lincei 1899 S.5; 8: 21
10. 10. James SP. Malaria in Mian Mir. In: Jennings WE, editor. Transactions of the Bombay Medical Conference, 1909. Bombay: Bennett, Coleman, 1909: 84-9
11. 11. McCullough D. The path between the seas: the creation of the Panama Canal, 1870-1914. New York: Simon & Schuster, 1978: 698
12. 12. Reed W, Carroll J, Agramonte A. Experimental yellow fever. Trans Assoc Am Physicians 1901; 16: 45-70
13. 13. Packard RM. Malaria dreams: postwar visions of health and development in the third world. Med Anthropol 1997; 17: 279-96
14. 14. Beadle C, Hoffman SL. History of malaria in the United States naval forces at war: World War I through the Vietnam conflict. Clin Infect Dis 1993; 16: 320-9
15. 15. Coatney GR. Pitfalls in a discovery: the chronicle of chloroquine. Am J Trop Med Hyg 1963; 12: 121-8
16. 16. Russel PF. Man's mastery of malaria. London: Oxford University Press, 1955
17. 17. Zucker JR. Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks. Emerg Infect Dis 1996; 2; 37-43
18. 18. Faust EC, Debakey L. Malaria mortality in the Southern United States for the year 1940, with supplementary data on malaria in other states. J Natl Malaria Soc 1942; 1: 125-31
19. 19. MacDonald G. The epidemiology and control of malaria. London: Oxford University Press, 1957
20. 20. United States Agency for International Development. Malaria: meeting the global challenge. AID science & technology in development series. Boston: Oelgeschlager, Gunn, & Hain Publishers, 1985
21. 21. Jukes TH. Insecticides in health, agriculture and the environment. Naturwissenschaften 1974; 61: 6-16
22. 22. Sharma VP. Re-emergence of malaria in India. Indian J Med Res 1996; 103; 26-45
23. 23. Atmosoedjono S. Malaria control in Indonesia since World War II. Wageningen Agricultural University Papers 1990; 90-7: 141-54
24. 24. Curtin PD. Malarial immunities in Nineteenth Century West Africa and the Caribbean. Parassitologia 1994; 36: 69-82
25. 25. Baird JK, Sismadi P, Masbar S, et al. A focus of endemic malaria in Central Java. Am J Trop Med Hyg 1996; 54: 98-104
26. 26. Lepers JP, Fontinille D, Rason MD, et al. Transmission and epidemiology of newly transmitted falciparum malaria in the central highland plateau of Madagascar. Ann Trop Med Parasitol 1991; 85: 297-304
27. 27. Reynolds DJ. The Demerara doctor. Perspectives in Health 1996; 1 (2) [online]. Available from: URL: http://www.paho. org/english/DPImag/Number2/dpi2pdemerara.html [Accessed 2000 Feb 29]
28. 28. Cruz MA. Human migration and the spread of malaria in Brazil. Parasitol Today 1987; 3: 166-70
29. 29. Trigg PI, Kondrachine AV. Commentary: malaria control in the 1990s. Bull WHO 1998; 76: 11-6
30. 30. Packard RM. 'No other logical choice': global malaria eradication and the politics of international health in the post-war era. Parassitologia 1998; 40: 217-29
31. 31. Butler D, Maurice J, O'Brien C. Time to put malaria control on the global agenda. Nature 1997, 386: 535-6
32. 32. Campbell CC. Malaria: an emerging and re-emerging global plague. FEMS Immunol Med Microbiol 1997; 18: 325-31
33. 33. Kondrachine AV, Trigg PI. Global overview of malaria. Indian J Med Res 1997; 106:39-52
34. 34. National Academy of Sciences (US). Vaccines Against malaria: hope in a gathering storm. Washington: National Academy Press, 1996
35. 35. Greenberg AE, Lobel HO. Mortality from plasmodium falciparum malaria in travelers from the United States, 1959 to 1987. Ann Intern Med 1990; 113: 326-7
36. 36. World Health Organization. World malaria situation in 1994: Part II, the Americas. Wkly Epidemiol Rec 1997; 72: 277-84
37. 37. World Health Organization. World malaria situation in 1994: Part III. Wkly Epidemiol Rec WHO 1997; 72: 285-90
38. 38. Feighner BH, Pak SI, Novakoski WL, et al. Reemergence of Plasmodium vivax malaria in the Republic of Korea. Emerg Infect Dis 1998; 4: 295-7
39. 39. Roberts DR, Laughlin LL, Hsheih P. DDT, global strategies, and a malaria control crisis. Emerg Infect Dis 1997; 3: 295-302
40. 40. Sharp BL, le Sueur D. Malaria in South Africa: the past, the present and selected implications for the future. S Afr Med J 1996; 86: 83-9
41. 41. Lepers JP, Deloron P, Andriamagatiana-Rason MD, et al. Newly transmitted plasmodium falciparum malaria in the central highland plateaux of Madagascar: assessment of clinical impact in a rural community. Bull WHO 1990; 68: 217-22
42. 42. Malakooti MA, Biomndo K, Shanks GD. Reemergence of epidemic malaria in the highlands of western Kenya. Emerg Infect Dis 1998; 4: 671-6
43. 43. Shukla RP, Pandey AC, Mathur A. Investigation of malaria outbreak in Rajasthan. Indian J Malariol 1995; 32: 119-28
44. 44. Martens WJ, Niessen LW, Rotmans J. Potential impact of global climate change on malaria risk. Environ Health Perspect 1995; 103: 458-64
45. 45. Baird JK, Basri H, Jones TR, et al. Resistance to antimalarials in northeastern Irian Jaya, Indonesia. Am J Trop Med Hyg 1991; 44: 640-4
46. 46. Baird JK, Leksana B, Masbar S, et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg 1997; 56: 621-6
47. 47. Hogh B, Gamage-Mendis A, Butcher GA, et al. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito sector. Am J Trop Med Hyg 1998; 58: 176-82
48. 48. Rieckmann KH, Davis DR, Halton DC. Plasmodium vivax resistance to chloroquine? Lancet 1989; 11: 1183-4
49. 49. Schwartz IK, Lackritz EM, Patchen LC. Chloroquine-resistant Plasmodium vivax from Indonesia. N Engl J Med 1991; 324: 927
50. 50. Baird JK, Basri H, Subianto B, et al. Treatment of chloroquine resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J Infect Dis 1995; 171: 1678-82
51. 51. Than M, Kyaw MP, Soe AY, et al. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans R Soc Trop Med Hyg 1995; 89: 307-8
52. 52. Garg M, Gopinathan N, Bodhe P, et al. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg 1995; 89: 656-7
53. 53. Phillips EJ, Keystone JS, Kain KC. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax acquired in Guyana, South America. Clin Infect Dis 1996; 23: 1171-3
54. 54. Baird JK, Wiady I, Fryauff DJ, et al. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg 1997; 56: 627-31
55. 55. Baird JK, Leksana B, Masbar S, et al. Whole blood chloroquine concentrations with Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 1997; 56: 618-20
56. 56. Wolff MS, Toniolo PC, Lee EW, et al. Blood levels ot organochlorine residues and risk of breast cancer. J Natl Cancer Inst 1993; 85: 648-52
57. 57. Krieger N, Wolff MS, Hiatt RA, et al. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst 1994; 86: 589-99
58. 58. Hunter DJ, Hankinson SE, Laden F, et al. Plasma organochlorine levels and risk of breast cancer. N Engl J Med 1997; 337: 1253-8
59. 59. Longnecker MP, Rogan WJ, Lucier G. The health effects of DDT and PCBS and an overview of organochlorines in public health. Ann Rev Public Health 1997; 18: 211-44
60. 60. Institute of Medicine. Malaria: obstacles & opportunities. In: Oaks Jr SC, Mitchell VS, Pearson GW, et al, editors. Washington DC: National Academy Press, 1991
61. 61. World Health Organization. Four international organizations unite to roll back malaria. World Health Organization Press Release WHO/77 of 30 October 1998. Accessed at http: //www.who.ch/
62. 62. World Health Organization. Multilateral perspective on malaria begins to take shape: tropical diseases newsletter no. 55, February 1998. Geneva: WHO, 1998
63. 63. Fontinille D, Lepers JP, Campbell GH, et al. Malaria transmission and vector biology in Manarintsoa, high plateau of Madagascar. Am J Trop Med Hyg 1990; 43: 107-15
64. 64. Pan American Health Organization. Status of malaria programs in the Americas. XLII Report. Washington, DC: Pan American Health Organization, 1994
65. 65. Pan American Health Organization. Report on the status of malaria programs in the Americas. HCP/HCT/149/99, August 1999
66. 66. Brogdon WG, McAllister JC. Insecticide resistance and vector control. Emerg Infect Dis 1998; 4: 605-14
67. 67. Roberts DR, Andre RG. Insecticide resistance issues in vector-borne disease control. Am J Trop Med Hyg 1994; 50 Suppl.: 21-34
68. 68. Bangs MJ. Doctoral dissertation. Bethesda (MD): Uniformed Services University of the Health Sciences, 1998
69. 69. World Wildlife Fund News. WWF urges World Health Assembly delegates to phase out deadly DDT pesticide (May 21 1999) (online]. Available from: URL: http://www.worldwildlife. org/toxics/whatsnew [Accessed 2000 Mar 3]
70. 70. Beadle C, McElroy PD, Oster CN, et al. Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design. J Infect Dis 1995; 172: 1047-54
71. 71. Jones TR, Baird JK, Bangs MJ, et al. Malaria vaccine study site in Irian Jaya, Indonesia: plasmodium falciparum incidence measurements, epidemiologic considerations in sample size estimation. Am J Trop Med Hyg 1994; 50: 210-8
72. 72. Pan American Health Organization. Status of malaria programs in the Americas. XLV Report. Washington DC: Pan American Health Organization, 1997
73. 73. Baird JK. Age-dependent characteristics of protection vs. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol 1998; 92: 367-90
74. 74. Baird JK. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today 1995; 11: 105-11
75. 75. Snow RW, Omumbo JA, Lowe B, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 1997; 349: 1650-4
76. 76. McElroy PD, Beier JC, Oster CN, et al. Dose-and time-dependent relations between infective Anopheles inoculation and outcomes of Plasmodium falciparum parasitemia among children in Western Kenya. Am J Epidemiol 1997; 145: 945-56
77. 77. Baird JK, Hoffman SL. Prevention of malaria in travelers. Med Clin North Am 1999; 83: 923-44
78. 78. White NJ, Nosten F, Looareesuwan S, et al. Averting a malaria disaster. Lancet 1999; 353: 1965-7
79. 79. White N. Antimalarial drug resistance and combination chemotherapy. Phil Trans R Soc Lond B Biol Sci 1999; 354: 739-49
80. 80. Price R, van Vugt M, Phaipun L, et al. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg 1999; 60: 547-55
81. 81. Nosten F, Hien TT, White NJ. Use of artemisinin derivatives for the control of malaria. Med Trop (Mars) 1998; 58 Suppl. 3: 45-9
82. 82. Price RN, Nosten F, Luxemberger C, et al. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1997; 91: 574-7
83. 83. Van Vugt M, Brockman A, Gemperli B, et al. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multi-drug resistant falciparum malaria. Antimicrob Agents Chemother 1998; 42: 135-9